Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2
Seeking Alpha News (Fri, 17-Jul 9:35 AM ET)
LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
Globe Newswire (Thu, 16-Jul 4:10 PM ET)
Jefferies Sticks to Their Buy Rating for Lifestance Health Group (LFST)
TipRanks (Thu, 16-Jul 9:05 AM ET)
Barclays Keeps Their Buy Rating on Lifestance Health Group (LFST)
TipRanks (Tue, 14-Jul 4:46 AM ET)
Lifestance Health Group (LFST) Receives a Buy from KeyBanc
TipRanks (Mon, 13-Jul 5:16 AM ET)
LifeStance Health Group Announces Pricing of Secondary Public Offering
Globe Newswire (Thu, 7-May 10:18 PM ET)
LifeStance Health Group Announces Launch of Secondary Public Offering
Globe Newswire (Thu, 7-May 4:51 PM ET)
LifeStance Delivers Robust Q1 2026 Growth: Revenue, Margins, and Earnings All Rise
Market Chameleon (Thu, 7-May 6:40 AM ET)
LifeStance Reports First Quarter 2026 Results
Globe Newswire (Thu, 7-May 6:00 AM ET)
LifeStance to Present at Upcoming Investor Conferences
Globe Newswire (Wed, 29-Apr 4:10 PM ET)
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Lifestance Health Group trades on the NASDAQ stock market under the symbol LFST.
As of July 17, 2026, LFST stock price climbed to $11.44 with 677,875 million shares trading.
LFST has a beta of 0.75, meaning it tends to be less sensitive to market movements. LFST has a correlation of 0.03 to the broad based SPY ETF.
LFST has a market cap of $4.37 billion. This is considered a Mid Cap stock.
Last quarter Lifestance Health Group reported $403 million in Revenue and $.04 earnings per share. This beat revenue expectation by $17 million and missed earnings estimates by -$.01.
In the last 3 years, LFST traded as high as $11.64 and as low as $3.74.
The top ETF exchange traded funds that LFST belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
LFST has outperformed the market in the last year with a price return of +160.0% while the SPY ETF gained +20.6%. LFST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +71.5% and +1.5%, respectively, while the SPY returned +6.4% and 0.0%, respectively.
LFST support price is $10.97 and resistance is $11.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFST shares will trade within this expected range on the day.